Wolverine Trading, LLC Co Diagnostics, Inc. Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.7 $22,470 - $37,821	22,248 New	22,248 $27,000
Q3 2021 Nov 12, 2021	SELL	$7.48 - $11.38 $23,389 - $35,585	-3,127 Reduced 10.92%	25,504 $248,000
Q2 2021 Aug 06, 2021	SELL	$7.16 - $9.56 $2,842 - $3,795	-397 Reduced 1.37%	28,631 $255,000
Q1 2021 May 14, 2021	BUY	$8.52 - $19.21 $55,414 - $124,941	6,504 Added 28.88%	29,028 $248,000
Q4 2020 Feb 12, 2021	BUY	$9.3 - $15.19 $8,035 - $13,124	864 Added 3.99%	22,524 $219,000
Q3 2020 Nov 13, 2020	BUY	$8.24 - $30.8 $85,794 - $320,689	10,412 Added 92.57%	21,660 $302,000
Q2 2020 Aug 13, 2020	BUY	$7.46 - $23.42 $83,910 - $263,428	11,248 New	11,248 $196,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $28M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.